Braidwell »

Geron Corporation shares owned by Braidwell

Quarter-by-quarter ownership of Geron Corporation (GERN) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Geron Corporation

Tip: Access up to 7 years of quarterly data

All positions including Geron Corporation held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Geron Corporation by Braidwell

Quarter filed Position value Share count Share price at filing
2024-12-31 $25M 7.0M 3.54

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Geron Corporation

RA Capital Management
BlackRock
Deep Track Capital
Vanguard Group
Vivo Capital
State Street Corporation
Goldman Sachs Group
Soleus Capital Management
Vestal Point Capital
Citadel Advisors
ClearBridge Advisors
Geode Capital Management
Eversept Partners
Millennium Management
Nantahala Capital Management

View all funds holding Geron Corporation